Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015 (2015), Article ID 347861, 7 pages
http://dx.doi.org/10.1155/2015/347861
Research Article

Anti-Inflammatory Property of Plantago major Leaf Extract Reduces the Inflammatory Reaction in Experimental Acetaminophen-Induced Liver Injury

1Department of Anatomy, Faculty of Medicine, Universiti Kebangsaan Malaysia, Jalan Yaacob Latif, Bandar Tun Razak, Cheras, 56000 Kuala Lumpur, Malaysia
2Department of Biomedical Science, Faculty of Health Sciences, Universiti Kebangsaan Malaysia, Jalan Raja Muda Abdul Aziz, 50300 Kuala Lumpur, Malaysia

Received 30 April 2015; Revised 16 July 2015; Accepted 21 July 2015

Academic Editor: Sonia Piacente

Copyright © 2015 Farida Hussan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Metha and M. R. Pinsky, “Drug-induced hepatotoxicity,” Medscape Reference: Drugs, Disease & Procedures, 2014, http://emedicine.medscape.com/article/169814-overview.
  2. R. Kaushal, K. R. Dave, and S. S. Katyare, “Paracetamol hepatotoxicity and microsomal function,” Environmental Toxicology and Pharmacology, vol. 7, no. 1, pp. 67–74, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Jaeschke, M. R. McGill, C. D. Williams, and A. Ramachandran, “Current issues with acetaminophen hepatotoxicity—a clinically relevant model to test the efficacy of natural products,” Life Sciences, vol. 88, no. 17-18, pp. 737–745, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Jaeschke, C. D. Williams, M. R. McGill, Y. Xie, and A. Ramachandran, “Models of drug-induced liver injury for evaluation of phytotherapeutics and other natural products,” Food and Chemical Toxicology, vol. 55, pp. 279–289, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. D. L. Laskin, “Macrophages and inflammatory mediators in chemical toxicity: a battle of forces,” Chemical Research in Toxicology, vol. 22, no. 8, pp. 1376–1385, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. J. W. Tomlinson, E. A. Walker, I. J. Bujalska et al., “11β-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response,” Endocrine Reviews, vol. 25, no. 5, pp. 831–866, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. I. J. Elenkov and G. P. Chrousos, “Stress hormones, Th1/Th2 patterns, pro/anti-inflammatory cytokines and susceptibility to disease,” Trends in Endocrinology & Metabolism, vol. 10, no. 9, pp. 359–368, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Nazaizadeh, P. Mikaili, M. Moloudizargari, S. Aghajanshakeri, and S. Javaherypour, “Therapeutic uses and pharmacological properties of Plantago major L. and its active constituents,” Journal of Basic and Applied Scientific Research, vol. 3, no. 9, pp. 212–221, 2013. View at Google Scholar
  9. A. B. Samuelsen, “The traditional uses, chemical constituents and biological activities of Plantago major,” Journal of Ethnopharmacology, vol. 71, no. 1-2, pp. 1–21, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Zubair, H. Nybom, C. Lindholm, and K. Rumpunen, “Major polyphenols in aerial organs of greater plantain (Plantago major L.), and effects of drying temperature on polyphenol contents in the leaves,” Scientia Horticulturae, vol. 128, no. 4, pp. 523–529, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Noor, M. Juing, B. J. Chee, B. L. Kueh, and Z. Othman, “Medicinal properties of Plantago major: hypoglycaemic and male fertility studies,” Pertanika Journal of Tropical Agricultural Science, vol. 23, no. 1, pp. 29–35, 2000. View at Google Scholar
  12. S. A. Aziz, T. L. See, L. Y. Khuay, K. Osman, and M. A. A. Bakar, “In vitro effects of Plantago major on urolithiasis,” Malaysian Journal of Medical Sciences, vol. 12, no. 2, pp. 22–26, 2005. View at Google Scholar
  13. C. B. Jin and H. M. Noor, “The hypoglycaemic effect of Plantago major leaf extract on alloxan-induced diabetic rats,” Journal of Tropical Medicinal Plants, vol. 7, no. 2, pp. 175–178, 2006. View at Google Scholar
  14. A. A. Malik, I. Anis, S. B. Khan et al., “Enzymes inhibiting lignans from Vitex negundo,” Chemical and Pharmaceutical Bulletin, vol. 52, no. 11, pp. 1269–1272, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. S. U. Yanpallewar, S. Sen, S. Tapas, M. Kumar, S. S. Raju, and S. B. Acharya, “Effect of Azadirachta indica on paracetamol-induced hepatic damage in albino rats,” Phytomedicine, vol. 10, no. 5, pp. 391–396, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. A. H. Atta and K. A. El-Sooud, “The antinociceptive effect of some Egyptian medicinal plant extracts,” Journal of Ethnopharmacology, vol. 95, no. 2-3, pp. 235–238, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. I. Türel, H. Özbek, R. Erten, A. C. Öner, N. Cengiz, and O. Yilmaz, “Hepatoprotective and anti-inflammatory activities of Plantago major L,” Indian Journal of Pharmacology, vol. 41, no. 3, pp. 120–124, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Govindappa, T. S. Sadananda, R. Channabasava, and V. B. Raghavendra, “In vitro anti-inflammatory, lipoxygenase, xanthine oxidase and acetycholinesterase inhibitory activity of Tecoma stans (L.) Juss. Ex kunth,” International Journal of Pharma and Bio Sciences, vol. 2, no. 2, pp. 275–285, 2011. View at Google Scholar · View at Scopus
  19. I. N. Beara, D. Z. Orčić, M. M. Lesjak, N. M. Mimica-Dukić, B. A. Peković, and M. R. Popović, “Liquid chromatography/tandem mass spectrometry study of anti-inflammatory activity of Plantain (Plantago L.) species,” Journal of Pharmaceutical and Biomedical Analysis, vol. 52, no. 5, pp. 701–706, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. M. E. Blazka, J. L. Wilmer, S. D. Holladay, R. E. Wilson, and M. I. Luster, “Role of proinflammatory cytokines in acetaminophen hepatotoxicity,” Toxicology and Applied Pharmacology, vol. 133, no. 1, pp. 43–52, 1995. View at Publisher · View at Google Scholar · View at Scopus
  21. L. P. James, L. W. Lamps, S. McCullough, and J. A. Hinson, “Interleukin 6 and hepatocyte regeneration in acetaminophen toxicity in the mouse,” Biochemical and Biophysical Research Communications, vol. 309, no. 4, pp. 857–863, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. G. P. Chrousos, F. Epstein, J. Flier, S. Reichlin, and S. Pavlou, “The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation,” The New England Journal of Medicine, vol. 332, no. 20, pp. 1351–1362, 1995. View at Publisher · View at Google Scholar · View at Scopus
  23. B. D. Cosgrove, B. M. King, M. A. Hasan et al., “Synergistic drug-cytokine induction of hepatocellular death as an in vitro approach for the study of inflammation-associated idiosyncratic drug hepatotoxicity,” Toxicology and Applied Pharmacology, vol. 237, no. 3, pp. 317–330, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Banerjee and M. Saxena, “Interleukin-1 (IL-1) family of cytokines: role in type 2 diabetes,” Clinica Chimica Acta, vol. 413, no. 15-16, pp. 1163–1170, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. M. E. Blazka, M. R. Elwell, S. D. Holladay, R. E. Wilson, and M. I. Luster, “Histopathology of acetaminophen-induced liver changes: role of interleukin 1α and tumor necrosis factor α,” Toxicologic Pathology, vol. 24, no. 2, pp. 181–189, 1996. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Xiao, E. C. Liong, Y. P. Ching et al., “Lycium barbarum polysaccharides protect mice liver from carbon tetrachloride-induced oxidative stress and necroinflammation,” Journal of Ethnopharmacology, vol. 139, no. 2, pp. 462–470, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. K. E. Chapman, A. E. Coutinho, Z. Zhang, T. Kipari, J. S. Savill, and J. R. Seckl, “Changing glucocorticoid action: 11β-Hydroxysteroid dehydrogenase type 1 in acute and chronic inflammation,” Journal of Steroid Biochemistry and Molecular Biology, vol. 137, pp. 82–92, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. M. W. Voice, J. R. Seckl, C. R. W. Edwards, and K. E. Chapman, “1β-hydroxysteroid dehydrogenase type 1 expression in 2S FAZA hepatoma cells is hormonally regulated: a model system for study of hepatic glucocorticoid metabolism,” Biochemical Journal, vol. 317, pp. 621–625, 1996. View at Google Scholar
  29. C. A. Dinarello, “Anti-inflammatory agents: present and future,” Cell, vol. 140, no. 6, pp. 935–950, 2010. View at Publisher · View at Google Scholar · View at Scopus